Inventor
HAO MING-HONG
US30 patents
⚠️ This page may combine multiple inventors who share the name “HAO MING-HONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
14 patentsUS6492393B1Dec 10, 2002
Compounds useful as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA70 citations96
US7241758B2Jul 10, 2007
Compounds useful as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA45 citations92
US7514458B2Apr 7, 2009
Anti-cytokine heterocyclic compounds
BOEHRINGER INGELHEIM PHARMA25 citations91
US7166628B2Jan 23, 2007
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA18 citations90
US7569568B2Aug 4, 2009
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA9 citations82
US7485657B2Feb 3, 2009
Anti-cytokine heterocyclic compounds
BOEHRINGER INGELHEIM PHARMA13 citations82
US7214802B2May 8, 2007
Anti-cytokine heterocyclic compounds
BOEHRINGER INGELHEIM PHARMA12 citations82
US7078419B2Jul 18, 2006
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA15 citations82
US6964956B2Nov 15, 2005
Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
BOEHRINGER INGELHEIM PHARMA15 citations82
US7405225B2Jul 29, 2008
Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
BOEHRINGER INGELHEIM PHARMA3 citations61
US7335657B2Feb 26, 2008
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA2 citations61
US7592332B2Sep 22, 2009
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA4 citations60
US7285545B2Oct 23, 2007
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA1 citations49
US7550461B2Jun 23, 2009
Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases
BOEHRINGER INGELHEIM PHARMA0 citations40
EISAI R&D MAN CO LTD
12 patentsUS10246480B2Apr 2, 2019
Compounds for the treatment of cancer
EISAI R&D MAN CO LTD5 citations83
US9730931B2Aug 15, 2017
Pyrimidine FGFR4 inhibitors
EISAI R&D MAN CO LTD7 citations83
US9434697B2Sep 6, 2016
Pyrimidine FGFR4 inhibitors
EISAI R&D MAN CO LTD8 citations83
US9796683B2Oct 24, 2017
Tetrasubstituted alkene compounds and their use
EISAI R&D MAN CO LTD6 citations80
US12251394B2Mar 18, 2025
Methods for the treatment of bladder cancer
EISAI R&D MAN CO LTD0 citations61
US11339188B2May 24, 2022
Compounds for the treatment of cancer
EISAI R&D MAN CO LTD0 citations61
US10912774B2Feb 9, 2021
Pyrimidine FGFR4 inhibitors
EISAI R&D MAN CO LTD0 citations61
US11498916B2Nov 15, 2022
Crystalline FGFR4 inhibitor compound and uses thereof
EISAI R&D MAN CO LTD0 citations60
US11926619B2Mar 12, 2024
Certain pladienolide compounds and methods of use
EISAI R&D MAN CO LTD1 citations59
US10618930B2Apr 14, 2020
Compounds for the treatment of cancer
EISAI R&D MAN CO LTD0 citations51
US10537571B2Jan 21, 2020
Pyrimidine FGFR4 inhibitors
EISAI R&D MAN CO LTD0 citations51
US10851065B2Dec 1, 2020
Tetrasubstituted alkene compounds and their use
EISAI R&D MAN CO LTD0 citations48